When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
Federal officials have celebrated a striking drop in drug overdoses across the country. But state-level data shows that Black people are suffering significantly worse outcomes than white people.
Every day seems to bring more exciting news. First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to treat cardiovascular and ...
The U.S. Food and Drug Administration has approved ... Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations ...
The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson disease (PD). Vyalev is the first and only subcutaneous 24-hour ...
(Office of the Special Narcotics Prosecutor in New York via AP) A recreational drug called “pink cocaine” is getting attention and causing confusion since it doesn’t typically contain cocaine. The ...
Those substances included "pink cocaine" – a recreational drug that typically is a mix of several drugs including methamphetamine, ketamine, MDMA and others – as well as cocaine ...
Clonazepam is a generic drug prescribed for panic disorder in adults and seizure disorders in adults and children. It comes as oral tablets and orally disintegrating tablets and is typically taken ...
Commonly marketed as an anti-aging product, nicotinamide riboside is an alternative form of vitamin B3 with few side effects. It may protect brain cells and lower the risk of heart disease. Every ...
This novel treatment is the first of its kind, offering a 24-hour continuous infusion of levodopa-based medication delivered subcutaneously. VYALEV, composed of foscarbidopa and foslevodopa ...
The US Food and Drug Administration (FDA) has approved foscarbidopa and foslevodopa (Vyalev, AbbVie), a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion ...